IGF-1 down-regulates IFN-γR2 chain surface expression and desensitizes IFN-γ/STAT-1 signaling in human T lymphocytes

Blood

Volumn 102, Issue 8, 2003, Pages 2933-2939

  Bernabei, Paola ^b   Bosticardo, Marita ^b   Losana, Giuliana ^b   Regis, Gabriella ^b   Di Paola, Francesca ^b   De Angelis, Stefania ^b   Giovarelli, Mirella ^b   Novelli, Francesco ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON RECEPTOR; GAMMA INTERFERON RECEPTOR 2; MONOCLONAL ANTIBODY; PHYTOHEMAGGLUTININ; SOMATOMEDIN C; STAT1 PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; BONE MARROW CELL; CELL CULTURE; CONTROLLED STUDY; DESENSITIZATION; DOWN REGULATION; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOBLAST; T LYMPHOCYTE;

EID: 0141993007     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-01-0100     Document Type: Article

References (47)

1. Martins G-A, Vieira L-Q, Cunha F-Q, Silva J-S. Gamma interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: a possible role in immune response control. Infect Immun. 1999;67:3864-3871.
2. Dalton D-K, Haynes L, Chu C-Q, Swain S, Wittmer S. Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med. 2000;192:117-122.
3. Chu C-Q, Wittmer D, Dalton D-K. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J Exp Med. 2000;192:123-128.
4. Lohman B-L, Welsh R-M. Apoptotic regulation of T cells and absence of immune deficiency in virus-infected gamma interferon receptor knockout mice. J Virol. 1998;72:7815-7821.
5. + T cell homeostasis by perforin and interferon-gamma. Science. 2000;290:1354-1358.
6. Refaeli Y, Van Parijs L, Alexander S-I, Abbas A-K. Interferon gamma is required for activation-induced death of T lymphocytes. J Exp Med. 2002;196:999-1005.
7. Liu Y, Janeway C-A. Interferon gamma plays a critical role in induced cell death of effector T cells: a possible third mechanism of self-tolerance. J Exp Med. 1990;172:1735-1738.
8. Novelli F, Bernabei P, Ozmen L, et al. Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha and beta-chains of its receptor. J Immunol. 1996;157:1935-1943.
9. Novelli F, D'Elios M-M, Bernabei P, et al. Expression and role in apoptosis of the alpha- and beta-chains of the IFN-gamma receptor on human Th1 and Th2 clones. J Immunol. 1997;159:206-213.
10. Bernabei P, Allione A, Rigamonti L, et al. Regulation of interferon-gamma receptor (IFN-gammaR) chains: a peculiar way to rule the life and death of human lymphocytes. Eur Cytokine Netw. 2001;12:6-14.
11. Skrenta H, Yang Y, Pestka S, Fathman C-G. Ligand-independent down-regulation of IFN-gamma receptor 1 following TCR engagement. J Immunol. 2000;164:3506-3511.
12. Valente G, Ozmen L, Novelli F, et al. Distribution of interferon-gamma receptor in human tissues. Eur J Immunol. 1992;22:2403-2412.
13. Bernabei P, Coccia E-M, Rigamonti L, et al. Interferon-gamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death. J Leukoc Biol. 2001;70:950-960.
14. Bach E-A, Szabo S-J, Dighe A-S, et al. Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T helper cell subsets. Science. 1995;270:1215-1218.
15. Pernis A, Gupta S, Gollob K-J, et al. Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. Science. 1995;269:245-247.
16. Groux H, Sornasse T, Cottrez F, et al. Induction of human T helper cell type 1 differentiation results in loss of IFN-gamma receptor beta-chain expression. J Immunol. 1997;158:5627-5631.
17. Rigamonti L, Ariotti S, Losana G, et al. Surface expression of the IFN-gamma R2 chain is regulated by intracellular trafficking in human T lymphocytes. J Immunol. 2000;164:201-207.
18. Allione A, Wells V, Forni G, Mallucci L, Novelli F. Beta-galactoside-binding protein (beta GBP) alters the cell cycle, up-regulates expression of the alpha- and beta-chains of the IFN-gamma receptor, and triggers IFN-gamma-mediated apoptosis of activated human T lymphocytes. J Immunol. 1998;161:2114-2119.
19. Allione A, Bernabel P, Bosticardo M, Arlotti S, Forni G, Novelli F. Nitric oxide suppresses human T lymphocyte proliferation through IFN-gamma-dependent and IFN-gamma-independent induction of apoptosis. J Immunol. 1999;163:4182-4191.
20. Lenardo M-J. Fas and the art of lymphocyte maintenance. J Exp Med. 1996;183:721-724.
21. Kooijman R, Hooghe-Peters E-L, Hooghe R. Prolactin, growth hormone, and insulin-like growth factor-I in the immune system. Adv Immunol. 1996;63:377-454.
22. Nguyen B-Y, Clerici M, Venzon D-J, et al. Pilot study of the immunologic effects of recombinant human growth hormone and recombinant insulin-like growth factor in HIV-infected patients. AIDS. 1998;12:895-904.
23. Tu W, Cheung P-T, Lau Y-L. Insulin-like growth factor 1 promotes cord blood T cell maturation and inhibits its spontaneous and phytohemagglutinin-induced apoptosis through different mechanisms. J Immunol. 2000;165:1331-1336.
24. Tu W, Cheung P-T, Lau Y-L. IGF-I increases interferon-gamma and IL-6 mRNA expression and protein production in neonatal mononuclear cells. Pediatr Res. 1999;46:748-754.
25. Tu W, Zhang D-K, Cheung P-T, Tsao S-W, Lau Y-L. Effect of insulin-like growth factor 1 on PHA-stimulated cord blood mononuclear cell telomerase activity. Br J Haematol. 1999;104:785-794.
26. Walsh P-T, O'Connor R. The insulin-like growth factor-I receptor is regulated by CD28 and protects activated T cells from apoptosis. Eur J Immunol. 2000;30:1010-1018.
27. Novelli F, Di Pierro F, Francia di Celle P, et al. Environmental signals influencing expression of the IFN-gamma receptor on human T cells control whether IFN-gamma promotes proliferation or apoptosis. J Immunol. 1994;152:496-504.
28. Schillaci R, Brocardo M-G, Galeano A, Roldan A. Downregulation of insulin-like growth factor-1 receptor (IGF-1R) expression in human T lymphocyte activation. Cell Immunol. 1998;183:157-161.
29. McQuillan D-J, Handley C-J, Campbell M-A, Bolis S, Milway V-E, Herington A-C. Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor-I in cultured bovine articular cartilage. Biochem J. 1986;240:423-430.
30. Massague J, Blinderman L-A, Czech M-P. The high affinity insulin receptor mediates growth stimulation in rat hepatoma cells. J Biol Chem. 1982;257:13958-13963.
31. Pestka S, Kotenko S-V, Muthukumaran G, Izotova L-S, Cook J-R, Garotta G. The interferon gamma (IFN-gamma) receptor: a paradigm for the multichain cytokine receptor. Growth Factor Rev. 1997;8:189-206.
32. Darnell J-E Jr, Kerr I-M, Stark G-R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415-1421.
33. Subramaniam P-S, Johnson H-M. Lipid microdomains are required sites for the selective endocytosis and nuclear translocation of IFN-gamma, its receptor chain IFN-gamma receptor-1, and the phosphorylation and nuclear translocation of STAT1 alpha. J Immunol. 2002;169:1959-1969.
34. Lamaze C, Dujeancourt A, Baba T, Lo C-G, Benmerah A, Dautry-Varsat A. Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol Cell. 2001;7:661-671.
35. Johnson E-W, Jones L-A, Kozak R-W. Expression and function of insulin-like growth factor receptors on anti-CD3-activated human T lymphocytes. J Immunol. 1992;148:63-71.
36. Stuart C-A, Meehan R-T, Neale L-S, Cintron N-M, Furlanetto R-W. Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes. J Clin Endocrinol Metab. 1991;72:1117-1122.
37. Zong C-S, Chan J, Levy D-E, Horvath C, Sadowski H-B, Wang L-H. Mechanism of STAT3 activation by insulin-like growth factor I receptor. J Biol Chem. 2000;275:15099-15105.
38. Hong F, Jaruga B, Kim W-H, et al. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest. 2002;110:1503-1513.
39. Caldenhoven E, Buitenhuis M, van Dijk T-B, et al. Lineage-specific activation of STAT3 by interferon-gamma in human neutrophils. J Leukoc Biol. 1999;65:391-396.
40. Sato T, Selleri C, Young N-S, Maciejewski J-P. Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-γ due to phosphorylation of Stat1 and Stat3. Blood. 1997;90:4749-4758.
41. Dighe A-S, Richards E, Old L-J, Schreiber R-D. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity 1994;1:447-456.
42. Shankaran V, Ikeda H, Bruce A-T, et al. IFN-gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 2001;410:1107-1111.
43. Kaplan D-H, Shankaran V, Dighe A-S, et al. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A. 1998;95:7556-7561.
44. Baserga R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res. 1995;55:249-252.
45. Dunn G-P, Bruce A-T, Ikeda H, Old L-J, Schreiber R-D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002;3:991-998.
46. Dummer R, Dobbeling U, Geertsen R, Willers J, Burg G, Pavlovic J. Interferon resistance of cutaneous T-cell lymphoma-derived clonal T-helper 2 cells allows selective viral replication. Blood. 2001;97:523-527.
47. + T cells. Nat Immunol. 2002;3:549-557.